FULC Fulcrum Therapeutics, Inc.

Fundamentals / CIK 0001680581 / USD

Fulcrum Therapeutics, Inc. reported $0 in revenue and a net loss of $76.34M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FULC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$90.45M$45.23M$0-$109.5MFY 2018 Net Income: -$32.59M2018FY 2019 Net Income: -$82.68M2019FY 2020 Revenue: $8.82MFY 2020 Net Income: -$70.82M2020FY 2021 Revenue: $19.16MFY 2021 Net Income: -$80.85M2021FY 2022 Revenue: $6.34MFY 2022 Net Income: -$109.9M2022FY 2023 Revenue: $2.81MFY 2023 Net Income: -$97.33M2023FY 2024 Revenue: $80.00MFY 2024 Net Income: -$9.72M2024FY 2025 Revenue: $0FY 2025 Net Income: -$74.88M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $80.00M $2.81M $6.34M $19.16M $8.82M -- --
Research & Development $56.10M $63.39M $71.80M $76.78M $69.70M $59.04M $71.07M $25.18M
Total Operating Expenses $84.77M $101.9M $113.5M $118.9M $100.2M $80.43M $84.22M $33.50M
Operating Income -$84.77M -$21.90M -$110.7M -$112.6M -$81.05M -$71.61M -$84.22M -$33.50M
EBITDA -$83.38M -$20.30M -$108.5M -$110.1M -$78.54M -$69.23M -$82.16M -$32.15M
Income Tax Expense $0 $0 -- -- -- -- -- --
Net Income -$74.88M -$9.72M -$97.33M -$109.9M -$80.85M -$70.82M -$82.68M -$32.59M
Basic EPS -$1.18 -$0.16 -$1.59 -$2.44 -$2.29 -$2.79 -$8.13 -$31.14
Diluted EPS -$1.18 -$0.16 -$1.59 -$2.44 -$2.29 -$2.79 -$8.13 -$31.14
Basic Shares Outstanding 63.4K 62.0K 61.3K 45.0K 35.4K 25.4K 11.0K 1.3K
Diluted Shares Outstanding 63.4K 62.0K 61.3K 45.0K 35.4K 25.4K 11.0K 1.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- $0 $0 -- $0
Research & Development $3.03M $12.44M $14.08M $15.42M $14.30M $12.99M $13.40M $11.71M
Total Operating Expenses $13.86M $29.31M $22.19M $22.69M $21.86M $19.82M $20.40M $19.43M
Operating Income -$13.86M -$29.31M -$22.19M -$22.69M -$21.86M -$19.82M -$20.40M -$19.43M
EBITDA -$13.56M -$29.11M -$21.85M -$22.35M -$21.56M -$19.52M -$20.05M -$19.06M
Net Income -$10.94M -$26.18M -$18.89M -$20.33M -$19.59M -$17.30M -$17.66M -$16.57M
Basic EPS -$0.14 -$0.34 -$0.25 -- -$0.31 -$0.28 -$0.28 --
Diluted EPS -$0.14 -$0.34 -$0.25 -- -$0.31 -$0.28 -$0.28 --
Basic Shares Outstanding 76.3M 76.3M 76.2M -- 62.6M 62.5M 62.5M --
Diluted Shares Outstanding 76.3M 76.3M 76.2M -- 62.6M 62.5M 62.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $197.5M $58.21M $25.56M $35.10M $35.41M $57.05M $96.71M $72.80M
Short-Term Investments -- -- -- -- -- -- $0 --
Cash & Short-Term Investments $197.5M $58.21M $25.56M $35.10M $35.41M $57.05M $96.71M $72.80M
Other Current Assets -- -- -- -- $0 $74K $284K $238K
Total Current Assets $357.5M $249.9M $242.2M $207.5M $226.0M $119.5M $100.1M $74.09M
Property, Plant & Equipment, Net $2.82M $3.90M $5.22M $6.91M $7.37M $8.40M $9.21M $10.55M
Other Non-Current Assets $538K $10K $2.01M $2.10M $542K $578K $59K $38K
Total Non-Current Assets $8.80M $10.79M $15.49M $19.17M $9.00M $10.07M $10.36M $11.68M
Total Assets $366.3M $260.7M $257.7M $226.7M $235.0M $129.6M $110.4M $85.77M
Accounts Payable $1.59M $1.16M $2.76M $3.64M $4.79M $4.08M $2.19M $1.26M
Deferred Revenue (Current) -- -- $0 $934K $4.71M $14.91M $3.99M --
Other Current Liabilities $258K $463K $396K $105K $74K $44K $49K $120K
Total Current Liabilities $13.05M $11.04M $13.68M $16.73M $19.20M $26.73M $12.14M $4.23M
Deferred Revenue (Non-Current) -- -- -- -- $1.68M $2.97M $6.01M --
Other Non-Current Liabilities $197K $197K $197K $197K $0 -- $55K $150K
Total Non-Current Liabilities $4.24M $6.64M $8.83M $11.02M $4.26M $7.67M $11.15M $5.54M
Total Liabilities $17.28M $17.68M $22.50M $27.74M $23.46M $34.40M $23.29M $9.77M
Total Debt (incl. Leases) $6.44M $8.63M $10.82M $13.42M -- -- -- --
Common Stock $67K $54K $62K $52K $41K $28K $23K $2.0K
Retained Earnings -$594.3M -$519.4M -$509.7M -$412.3M -$302.5M -$221.6M -$150.8M -$68.12M
Accumulated Other Comp. Income $174K $130K -$136K -$797K -$397K -$2.0K -- --
Total Stockholders' Equity $349.0M $243.0M $235.2M $198.9M $211.5M $95.18M $87.15M -$63.67M
Total Equity $349.0M $243.0M $235.2M $198.9M $211.5M $95.18M $87.15M -$63.67M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $116.4M $48.47M $50.26M $197.5M $47.08M $42.59M $42.18M $58.21M
Cash & Short-Term Investments $116.4M $48.47M $50.26M $197.5M $47.08M $42.59M $42.18M $58.21M
Other Current Assets -- -- -- -- -- $69K -- --
Total Current Assets $310.8M $322.9M $338.7M $357.5M $205.9M $219.4M $232.6M $249.9M
Property, Plant & Equipment, Net $0 $0 $2.49M $2.82M $3.17M $3.27M $3.55M $3.90M
Other Non-Current Assets $9.0K $9.0K $546K $538K $9.0K $12K $10K $10K
Total Non-Current Assets $9.0K $1.10M $8.10M $8.80M $8.99M $9.46M $10.09M $10.79M
Total Assets $310.8M $324.0M $346.8M $366.3M $214.9M $228.8M $242.6M $260.7M
Accounts Payable $509K $3.42M $2.45M $1.59M $2.86M $1.75M $1.51M $1.16M
Other Current Liabilities $126K $174K $308K $258K $236K $173K $441K $463K
Total Current Liabilities $8.59M $10.30M $9.86M $13.05M $11.63M $8.98M $8.10M $11.04M
Other Non-Current Liabilities $197K $197K $197K $197K $197K $197K $197K $197K
Total Non-Current Liabilities $197K $2.96M $3.60M $4.24M $4.86M $5.47M $6.06M $6.64M
Total Liabilities $8.78M $13.26M $13.47M $17.28M $16.49M $14.46M $14.16M $17.68M
Total Debt (incl. Leases) $6.83M $5.28M $5.87M $6.44M $7.01M $7.57M $8.11M $8.63M
Common Stock $76K $76K $67K $67K $54K $54K $54K $54K
Retained Earnings -$650.3M -$639.3M -$613.2M -$594.3M -$573.9M -$554.3M -$537.1M -$519.4M
Accumulated Other Comp. Income -$759K -$567K -$513K $174K $241K $82K $70K $130K
Total Stockholders' Equity $302.0M $310.7M $333.3M $349.0M $198.4M $214.4M $228.5M $243.0M
Total Equity $302.0M $310.7M $333.3M $349.0M $198.4M $214.4M $228.5M $243.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$74.88M -$9.72M -$97.33M -$109.9M -$80.85M -$70.82M -$82.68M -$32.59M
Depreciation & Amortization $1.39M $1.59M $2.17M $2.41M $2.52M $2.38M $2.05M $1.34M
Stock-Based Compensation $12.47M $14.55M $14.80M $13.35M $11.07M $7.35M $4.22M $2.16M
Change in Receivables $2.10M -$1.56M -$308K $908K -$606K $531K -- --
Change in Payables $428K -$1.59M -$853K -$1.18M $973K $1.77M $803K -$20K
Operating Cash Flow -$60.06M -$2.22M -$90.97M -$97.05M -$78.48M -$53.66M -$39.48M -$22.56M
Capital Expenditure -$314K -$278K -$508K -$1.96M -$1.71M -$1.34M -$853K -$8.98M
Free Cash Flow -$60.38M -$2.50M -$91.47M -$99.01M -$80.19M -$55.00M -$40.34M -$31.54M
Purchases of Investments -$180.2M -$178.6M -$194.9M -$151.2M -$216.2M -$124.3M -- --
Investing Cash Flow $30.72M $32.23M -$36.69M $12.41M -$129.7M -$57.14M -$944K -$8.98M
Common Stock Issued $4.17M $2.75M $777K $3.52M $3.67M $1.43M $249K $12K
Financing Cash Flow $168.7M $2.75M $118.1M $84.32M $186.5M $71.13M $64.34M $105.0M
Net Change in Cash $139.3M $32.76M -$9.54M -$314K -$21.64M -$39.66M $23.92M $73.48M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$10.94M -$26.18M -$18.89M -$20.33M -$19.59M -$17.30M -$17.66M -$16.57M
Depreciation & Amortization $300K $200K $338K $347K $300K $300K $353K $369K
Stock-Based Compensation $2.17M $3.27M $3.86M $3.07M $3.36M $2.88M $3.17M $2.48M
Change in Receivables $0 $0 $0 $0 $0 $979K $1.12M $1.56M
Change in Payables -$2.92M $975K $858K -$1.10M $946K $244K $343K -$2.70M
Operating Cash Flow -$13.38M -$16.04M -$18.75M -$16.80M -$14.19M -$13.82M -$15.26M -$16.76M
Capital Expenditure $0 -$108K -$8.0K -$159K -$90K -$65K $0 -$231K
Free Cash Flow -$13.38M -$16.15M -$18.76M -$16.96M -$14.28M -$13.88M -$15.26M -$16.99M
Purchases of Investments $0 -$24.22M -$155.3M -$26.14M -$17.29M -$76.39M -$60.40M -$21.41M
Investing Cash Flow $81.13M $13.78M -$128.2M -$1.05M $18.61M $13.93M -$777K $2.26M
Common Stock Issued $198K $356K $21K $3.80M $64K $301K $0 $83K
Financing Cash Flow $198K $356K -$312K $168.3M $64K $301K $0 $83K
Net Change in Cash $67.94M -$1.90M -$147.3M $150.5M $4.49M $414K -$16.03M -$14.42M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -27.4% -3945.2% -1774.9% -423.0% -811.6% -- --
Net Profit Margin -- -12.2% -3470.1% -1732.4% -421.9% -802.7% -- --
Return on Equity (ROE) -21.5% -4.0% -41.4% -55.2% -38.2% -74.4% -94.9% --
Return on Assets (ROA) -20.4% -3.7% -37.8% -48.5% -34.4% -54.7% -74.9% -38.0%
Current Ratio 27.40x 22.63x 17.71x 12.41x 11.77x 4.47x 8.24x 17.52x
Quick Ratio 15.14x 5.27x 1.87x 2.10x 1.84x 2.13x 7.97x 17.21x
Debt to Equity 0.02x 0.04x 0.05x 0.07x -- -- -- --
Revenue Growth (YoY) -100.0% +2752.0% -55.8% -66.9% +117.2% -- -- --
5Y Revenue / Share Growth -100.0% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -- -- -- -27.4%
Net Profit Margin -- -- -- -- -- -- -- -12.2%
Return on Equity (ROE) -25.3% -27.4% -22.8% -21.5% -35.8% -34.2% -0.2% -4.0%
Return on Assets (ROA) -24.6% -26.2% -21.9% -20.4% -33.1% -32.0% -0.2% -3.7%
Current Ratio 36.19x 31.35x 34.33x 27.40x 17.70x 24.42x 28.71x 22.63x
Quick Ratio 13.56x 4.71x 5.10x 15.14x 4.05x 4.74x 5.21x 5.27x
Debt to Equity 0.02x 0.02x 0.02x 0.02x 0.04x 0.04x 0.04x 0.04x
Revenue Growth (YoY) -- -- -- -- -- -100.0% -- -100.0%
Operating Income Growth (YoY) -- -- -- -- -- -137.7% -- --
Net Income Growth (YoY) -- -- -- -- -- -131.2% -- --
EPS Growth (YoY) -- -- -- -- -- -131.5% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -123.5% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -123.6% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001680581) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:41 UTC · Open in terminal